![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vycor Medical Inc (QB) | USOTC:VYCO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0899 | 0.061 | 0.0899 | 0.00 | 13:30:25 |
CUSIP No. n/a
|
13D
|
1.
|
NAMES OF REPORTING PERSONS
Peter C. Zachariou
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
|
|
3.
|
SEC USE ONLY
|
|
4.
|
SOURCE OF FUNDS
OO (see Item 3, below)
|
|
5.
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
o
|
|
6.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7.
|
SOLE VOTING POWER 67,138
|
8.
|
SHARED VOTING POWER 0
|
|
9.
|
SOLE DISPOSITIVE POWER 67,138
|
|
10.
|
SHARED DISPOSITIVE POWER 0
|
|
11.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
67,138
|
|
12.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
|
|
13.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
25.7%
|
|
14.
|
TYPE OF REPORTING PERSON
CO
|
(a)
|
The Reporting Person is the beneficial owner of 67,138 shares of Company Series D, which are convertible by their terms into 312,270 shares of the Company’s common stock, representing approximately 25.71% of the outstanding shares of the Company’s Series D. The Reporting Person believes the number of shares of the Company’s Series D outstanding common stock to be 261,167 as of February 5, 2016. The Reporting Person has also separately reported the ownership of Warrants to purchase an aggregate of 211,239 Common Shares. Said amount includes all shares issuable to the Reporting Person on account of Warrants held by the Reporting Person exercisable within sixty (60) days of the date of this report. Other than as described therein, the Reporting Person does not own any other securities of the Company.
|
(b)
|
The Reporting Person has the sole power to vote and dispose of the 64,868 shares of Series D.
|
(c)
|
Except for the transactions described in the Explanatory Note above, the Reporting Person did not effect any transactions in the issuer’s securities within the past 60 days.
|
(d)
|
No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Reporting Person’s securities.
|
(e)
|
Not applicable.
|
Dated: February 15, 2016
|
||
/s/ Peter C. Zachariou
|
||
Peter C. Zachariou
|
||
1 Year Vycor Medical (QB) Chart |
1 Month Vycor Medical (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions